However, it is noteworthy that JAK2-mutated MPN patients were more likely to develop endodermal tumors, whereas tumors found in those with CALR mutation were more likely to be mesodermal origin (p = 0.027). This evidence concerns the gene CALR and myeloproliferative disorder.